• FirefoxInstall the new Firefox »
  •  Dow Down 0.45% Nasdaq Down 0.49%

    Actavis plc (ACT)

    -NYSE
    291.36 Up 1.58(0.55%) Feb 27, 4:03PM EST
    |After Hours : 291.10 Down 0.26 (0.09%) Feb 27, 6:55PM EST
    Add to Portfolio
    Prev Close:289.78
    Open:290.08
    Bid:291.35 x 200
    Ask:291.44 x 200
    1y Target Est:325.22
    Beta:0.74
    Earnings Date:Apr 28 - May 4 (Est.)
    Day's Range:289.86 - 292.62
    52wk Range:184.71 - 296.77
    Volume:3,747,630
    Avg Vol (3m):2,781,220
    Market Cap:77.58B
    P/E (ttm):N/A
    EPS (ttm):-7.42
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Comparison

    Symbol% ChgMkt Cap
    ACTUp 0.55%77.58B
    MYLUp 0.14%21.46B
    NVSDown 0.58%245.62B
    TEVAUp 0.94%48.57B

    Key Statistics

    Forward P/E (1 yr):13.76
    P/S (ttm):5.91
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-15) :17.57
    Quarterly EPS Est (Mar-15) :4.05
    Mean Recommendation*:1.6
    PEG Ratio (5 yr expected):0.83

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Actavis plc, a specialty pharmaceutical company, develops, manufactures, markets, and distributes generic, branded generic, branded, biosimilar, and over-the-counter (OTC) pharmaceutical products. View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback